Willow Biosciences (TSE:WLLW) Stock Price Down 10% – Should You Sell?

Willow Biosciences Inc. (TSE:WLLWGet Free Report) shares traded down 10% during trading on Friday . The company traded as low as C$0.09 and last traded at C$0.09. 205,000 shares were traded during trading, an increase of 170% from the average session volume of 75,960 shares. The stock had previously closed at C$0.10.

Willow Biosciences Price Performance

The company has a market capitalization of C$12.98 million, a price-to-earnings ratio of -1.67 and a beta of 1.13. The company’s 50 day simple moving average is C$0.10 and its 200-day simple moving average is C$0.10. The company has a current ratio of 0.70, a quick ratio of 19.71 and a debt-to-equity ratio of 131.61.

Willow Biosciences Company Profile

(Get Free Report)

Willow Biosciences Inc, a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation.

Featured Stories

Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.